Erectile Dysfunction Devices Market worth $2.7 billion | Boston Scientific Corporation (US), Rigicon, Inc. (US), Coloplast Group (Denmark), Promedon GmbH (Argentina)

Erectile Dysfunction Devices Market in terms of revenue was estimated to be worth $1.7 billion in 2023 and is poised to reach $2.7 billion by 2028, growing at a CAGR of 8.8% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by growing research and development around shockwave therapy used for erectile dysfunction treatment and the rise in the geriatric population, which are more prevalent in prostate cancers.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=195209494&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

The implants segment is expected to account for the largest share in 2022.

The erectile dysfunction devices market, by type, has been segmented into vacuum constriction devices, implants, shockwave therapy, and other device types. The implants segment accounted for the largest share of erectile dysfunction devices by type, in 2022. The large share of this segment is attributed to its durability and advancements in implant technology which are expected to drive the erectile dysfunction devices market.

The vascular disorders and diabetes segment held the largest market share in the erectile dysfunction devices market.

By cause, the global erectile dysfunction devices market is broadly segmented into vascular disorders and diabetes, neurological disorders, and other causes. The vascular disorders and diabetes segment has accounted for the largest share by cause, in 2022. The growing incidence of diabetes and age related CVDs will drive the market during the forecast period.

North America dominates the global erectile dysfunction devices market.

Based on the region, the erectile dysfunction devices market is segmented into North America, Europe, Asia Pacific, and Rest of the World. The North American market is driven by the growing number of prostate cancer and the number of ASCs in the region. Asia Pacific is the second-largest market for erectile dysfunction devices, characterized by an increase in the geriatric population coupled with a rise in the prevalence of CVDs are the major factors driving the market in Asia Pacific.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=195209494&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

Erectile Dysfunction Devices Market Dynamics:

Drivers:

1. Increase in prevalence of prostate cancer

Restraints:

1. Risk associated with the use of erectile dysfunction devices

Opportunities:

1. Technological advancement

Challenges:

1. Low awareness regarding prostate health among men

Key Market Players:

Major players in the erectile dysfunction devices market include Boston Scientific Corporation (US), Rigicon, Inc. (US), Coloplast Group (Denmark), Promedon GmbH (Argentina), and Zephyr Surgical Implants (Switzerland).

Recent Developments:

In 2023, Rigicon, Inc. (US) introduced the HL-LEVINE Combo Prosthesis Tool, which is a combination of the HL dilator tool and the traditional Furlow instrument, which are both used for implant surgery.

In 2022, Advanced MedTech Holdings (Singapore) acquired Shenzhen Huikang Medical Apparatus Co., Ltd. (China). This acquisition expanded Advanced MedTech's urological market access in China via a comprehensive nationwide sales and service network and an established local R&D, manufacturing, and supply chain ecosystem.

In 2022, Wikkon's extracorporeal shock wave lithotripter, model HK.ESWL-108A was successfully installed at Maria Clinic, Dili, East Timor.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=195209494&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.